Waystar (WAY) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
3 Nov, 2026Executive summary
Q3 revenue rose 21.2% YoY to $325.6M; adjusted EBITDA was $139.3M, up 24%, with a 42.8% margin.
Strong bookings and demand reflected provider adoption of broader connected-platform and AI-enabled capabilities.
9M revenue reached $959.2M and adjusted EBITDA was $411.4M, supported by subscription revenue and higher client transaction volumes.
Financial highlights
Q3 subscription revenue was $180.7M, up 34%; volume-based revenue was $142.9M, up 8%.
Q3 operating income was $61.3M versus $60.2M; GAAP net income was $31.0M versus $30.6M, with diluted EPS of $0.16 versus $0.17.
Q3 non-GAAP net income was $87.1M and diluted non-GAAP EPS was $0.44.
Q3 operating cash flow was $103.9M and unlevered free cash flow was $114.8M; YTD UFCF conversion was 65%.
Outlook and guidance
FY2026 revenue guidance is $1.277B–$1.287B, midpoint $1.282B, representing 17% YoY growth; normalized organic growth at midpoint is 11%.
FY2026 adjusted EBITDA guidance is $543M–$549M, midpoint $546M, or 43% margin.
Q4 revenue growth faces ~4 points of pressure from print-to-digital mix, slower Iodine revenue conversion and prior-year fast-ramping implementations; normalized growth is ~10%.
Iodine is expected to be accretive in FY2027; formal 2027 guidance is expected next quarter.
Latest events from Waystar
- AI-driven automation and data scale fuel growth, profitability, and measurable client outcomes.WAY
Investor Day 2026 - Q2 revenue up 18% to $320M, margins strong, guidance raised, and major acquisition completed.WAY
Q2 2026 - AI-powered automation and data integration drive efficiency, growth, and industry leadership.WAY
46th Annual William Blair Growth Stock Conference - Q2 revenue rose 15% to $270.7M, guidance was raised, and a $1.25B acquisition was announced.WAY
Q2 2025 - $1.25B AI-driven deal expands market by 15% and targets $15M+ in cost synergies.WAY
M&A Announcement - Q3 revenue up 22% to $240.1M, 40% EBITDA margin, $1B+ IPO, and raised full-year guidance.WAY
Q3 2024 - Q2 revenue up 20% to $234.5M, with strong margins and $1B+ debt reduction post-IPO.WAY
Q2 2024 - AI-driven healthcare payments platform achieves strong growth and industry leadership.WAY
43rd Annual J.P. Morgan Healthcare Conference 2025 - 2024 revenue up 19%, EBITDA margin 40.6%, net leverage 2.8x; 2025 targets 10% normalized growth.WAY
Q4 2024